Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway
Bing‐Wu Wang(Weifang Medical University), Yong Liu(Tango Therapeutics (United States)), Junnian Zheng(Xuzhou Medical College), Jiehui Di(Xuzhou Medical College), Hui Hou(Wuhan University of Technology), Yanping Zhang(Cell and Gene Therapy Catapult), Zhongjun Zhao(Xuzhou Medical College), Xuefei Zhong(Jiangsu University), Hao Cui(Xuzhou Medical College), Jian Gao(Xuzhou Medical College)
Cited by 8
Related Papers
Signaling to p53: Ribosomal Proteins Find Their Way
|Cancer Cell|2009|569
Three-photon imaging of mouse brain structure and function through the intact skull
|Nature Methods|2018|349
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome
|Oncotarget|2015|212
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189